Present state bias in transition ratings was accurately estimated in simulated and real data.

Minimal important change Patient-reported outcomes Present state bias Reliability Transition ratings Validity

Journal

Journal of clinical epidemiology
ISSN: 1878-5921
Titre abrégé: J Clin Epidemiol
Pays: United States
ID NLM: 8801383

Informations de publication

Date de publication:
03 2022
Historique:
received: 16 08 2021
revised: 14 11 2021
accepted: 22 12 2021
pubmed: 30 12 2021
medline: 4 5 2022
entrez: 29 12 2021
Statut: ppublish

Résumé

Patient-reported transition ratings are supposed to reflect the change between a previous baseline health state and a present follow-up state, but may reflect the present state to a greater extent. This so-called "present state bias" (PSB) potentially threatens the validity of transition ratings. Several criteria have been proposed to assess PSB. We examined how well these criteria perform and to which extent confirmatory factor analysis (CFA) for categorical data provides an accurate assessment of the degree of PSB. We simulated multiple samples with baseline and follow-up item responses to a hypothetical questionnaire, and transition ratings. The samples varied with respect to various distributional characteristics and the degree of PSB. The performance of criteria proposed in the literature, and a new CFA-based criterion, were evaluated by the proportion of explained variance in PSB. In addition, four real datasets were analyzed. The known criteria explained 36-74% of the variance in PSB. A new CFA-based criterion, namely the ratio of the factor loadings of the transition ratings plus one, explained 81-98% of the variance in PSB across the samples. Present state bias in transition ratings can be estimated accurately using CFA.

Identifiants

pubmed: 34965478
pii: S0895-4356(21)00430-3
doi: 10.1016/j.jclinepi.2021.12.024
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

128-136

Informations de copyright

Copyright © 2021. Published by Elsevier Inc.

Auteurs

Berend Terluin (B)

Department of General Practice, Amsterdam Public Health research institute, Amsterdam UMC, Vrije Universiteit Amsterdam, de Boelelaan 1117, 1081 HV Amsterdam, The Netherlands. Electronic address: b.terluin@amsterdamumc.nl.

Philip Griffiths (P)

Patient Centered Endpoints, IQVIA, Reading, United Kingdom. Electronic address: pip.griffiths@iqvia.com.

Andrew Trigg (A)

Patient-Centered Outcomes, Adelphi Values, Adelphi Mill, Bollington, Cheshire, SK10 5JB, United Kingdom. Electronic address: andrew.trigg@adelphivalues.com.

Caroline B Terwee (CB)

Department of Epidemiology and Data Science, Amsterdam Public Health research institute, Amsterdam UMC, Vrije Universiteit Amsterdam, de Boelelaan 1117, 1081 HV Amsterdam, The Netherlands. Electronic address: cb.terwee@amsterdamumc.nl.

Jakob B Bjorner (JB)

QualityMetric, Johnston, RI, USA; Department of Public Health, University of Copenhagen, Copenhagen, Denmark. Electronic address: jbjorner@qualitymetric.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH